Humana details plans to grow its primary care clinicsnews2025-06-18T14:17:04+00:00June 18th, 2025|Endpoints News|
Eli Lilly to buy gene editing biotech Verve Therapeutics for up to $1.3Bnews2025-06-17T11:15:43+00:00June 17th, 2025|Endpoints News|
NextCure inks ADC deal with Simcere Zaimingnews2025-06-16T14:09:21+00:00June 16th, 2025|Endpoints News|
Supernus to acquire Sage Therapeutics for about $561Mnews2025-06-16T11:35:45+00:00June 16th, 2025|Endpoints News|
Former CEO Anne Wojcicki wins bid for 23andMenews2025-06-13T21:54:56+00:00June 13th, 2025|Endpoints News|
BioNTech to acquire CureVac in all-stock deal valued at $1.25Bnews2025-06-12T11:35:52+00:00June 12th, 2025|Endpoints News|
Novo marks seventh cardiometabolic deal of the year with Deep Apple Therapeuticsnews2025-06-11T11:00:15+00:00June 11th, 2025|Endpoints News|
BMS’ RayzeBio bags rights for Philochem’s radiopharma asset for $350M upfrontnews2025-06-11T10:39:03+00:00June 11th, 2025|Endpoints News|
At a crossroads, biotechs are passing on reverse mergers in 2025news2025-06-06T12:46:10+00:00June 6th, 2025|Endpoints News|
